|
Malaysian Biotech to Post Double Digit Growth
By Shushmul Maheshwari
RNCOS E-Services Pvt. Ltd.
Email: press@rncos.com
http://www.rncos.com/
Wednesday - November 25, 2009
Category: Investment, Biotech
Malaysia has emerged as a new hub for biotechnology professionals. Malaysian biotechnology market has been witnessing continuous growth in investments due to country's rich biodiversity, increasing government efforts to promote the industry and availability of low-cost human resources. According to our new research study "Emerging Biotech Sector in Malaysia" the Malaysian biotech market is projected to grow at a CAGR of around 21% during 2010-2012.
The report presents extensive study on the biotechnology market in Malaysia, with focus on present and future trends to enable clients understand the market dynamics. With increasing government efforts to develop biotech market at global level, the Malaysian biotech market will experience a robust growth in next few years. In this regard, the report provides ample information on the current government initiatives and their significance in the development of the industry.
We have also studied different segments of the industry in order to identify key trends shaping up within the market. After a thorough evaluation, we have found that healthcare biotech segment has the highest potential in the overall biotech market in Malaysia. Besides this, the agriculture biotech market is also expected to post strong growth mainly because of country's expertise in the sector. Besides this, the report also provides an overview of certain roadblocks that are restraining the growth of the industry and also gives certain useful recommendations that will prove beneficial for both clients and government in future.
We believe that regulatory environment plays an important role in the development of biotech industry and our research study provides a complete view of the regulatory fram ework of the biotech industry in Malaysia.
"Emerging Biotech Sector in Malaysia" also provides brief business profile of the key players in the Malaysian biotech market. This will give our clients a competitive edge over t their competitors in the market. Overall, our research study provides valuable information to clients looking to venture into this market and helps them to devise strategies while going for an investment/partnership in the concerned market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM234.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Published at the www.InvestorIdeas.com Investing, Research and Industry Articles News Feed - Investorideas.com Financial Article Feed
Become an Investorideas.com Member and access some of our best investor research tools: Investing in Renewable Energy, Environment and Water Stocks
Become an Investorideas.com Member - Gain login access to 8 global stock directories including renewable energy stocks directory, environment stocks, water stocks, fuel cell stocks, biotech stocks, defense stocks, natural gas stocks, oil and gas stocks as well as the Insiders Corner investor newsletter covering insider buying trends on small cap stocks.
Investors: Sign up for free newsletter, stock and sector news alerts at Investorideas.com. Or publish your own stock picks and share your investing and trading ideas with other investors. Publish your investor ideas today!
www.InvestorIdeas.com - Big Ideas for the Small Cap Investor
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.
|
